Skip to main content

Drug companies told to do more to tackle 'superbug' crisis

LONDON, Jan 23 (Reuters) - Drugmakers' response to the threat posed by "superbugs" remains patchy even after years of warnings, according to the first analysis of individual companies' efforts to tackle the antibiotic resistance crisis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.